From oxygen sensing to heart failure

Antioxidants and Redox Signaling

Volumn 9, Issue 6, 2007, Pages 653-660

  Suzuki, Yuichiro J ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOPULMONARY FUNCTION; CARDIOPULMONARY HEMODYNAMICS; CONFERENCE PAPER; HEART FAILURE; HUMAN; HYPOXIA; HYPOXIC LUNG VASOCONSTRICTION; OXYGEN SENSING; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SLEEP APNEA SYNDROME;

ANIMALS; ANOXIA; HEART DISEASES; HUMANS; HYPERTENSION, PULMONARY; OXYGEN; SLEEP APNEA, OBSTRUCTIVE;

EID: 34249062370     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2007.1580     Document Type: Conference Paper

References (64)

1. Ago T and Sadoshima J. Thioredoxin1 as a negative regulator of cardiac hypertrophy. Antioxid Redox Signal 9: 679-687, 2007.
2. Bassetti C, Aldrich MS, and Quint D. Sleep-disordered breathing in patients with acute supra- and infratentorial strokes. A prospective study of 39 patients. Stroke 28: 1765-1772, 1997.
3. Bendall JK, Cave AC, Heymes C, Gall N, and Shah AM. Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation 105: 293-296, 2002.
4. Bradley TD, Rutherford R, Grossman RF, Lue F, Zamel N, Moldofsky H, and Phillipson EA. Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. Am Rev Respir Dis 131: 835-839, 1985.
5. - current elicited by beta1 integrin stretch in rabbit ventricular myocytes. J Gen Physiol 124: 273-287, 2004.
6. 2 sensor. J Biol Chem 273: 3320-3326, 1998.
7. Cataldi A, Bianchi G, Rapino C, Sabatini N, Centurionc L, Di Giulio C, Bosco D, and Antonucci A. Molecular and morphological modifications occurring in rat heart exposed to intermittent hypoxia: role for protein kinase C alpha. Exp Gerontol 39: 395-405, 2004.
8. Chandel NS and Schumacker PT. Cellular oxygen sensing by mitochondria: old questions, new insight. J Appl Physiol 88: 1880-1889, 2000.
9. Chemla D, Castelain V, Herve P, Lecarpentier Y, and Brimioulle S. Haemodynamic evaluation of pulmonary hypertension. Eur Respir J 20: 1314-1331, 2002.
10. Chen L, Einbinder E, Zhang Q, Hasday J, Balke WC, and Scharf SM. Oxidative Stress and Left Ventricular Function with Chronic Intermittent Hypoxia in Rats. Am J Respir Crit Care Med 172:915-920, 2005.
11. Duranteau J, Chandel NS, Kulisz A, Shao Z, and Schumacker PT. Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. J Biol Chem 273: 11619-11624, 1998.
12. Dyken ME, Somers VK, Yamada T, Ren ZY, and Zimmerman MB. Investigating the relationship between stroke and obstructive sleep apnea. Stroke 27: 401-407, 1996.
13. Farber HW and Loscalzo J. Pulmonary arterial hypertension. N Engl J Med 351: 1655-1665, 2004.
14. Fitzgerald RS, Shirahata M, Balbir A, and Grossman CE. Oxygen sensing in the carotid body and its relation to heart failure. Antioxid Redox Signal 9: 745-749, 2007.
15. Fletcher EC. Invited review: Physiological consequences of intermittent hypoxia: systemic blood pressure. J Appl Physiol 90: 1600-1605, 2001.
16. Griendling KK, Minieri CA, Ollerenshaw JD, and Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74: 1141-1148, 1994.
17. Hashimoto T, Sugiyama A, and Taguchi S. Hypoxia-induced adaptational shift in MHC-beta isoform expression in rat ventricles. Jpn J Physiol 55: 109-115, 2005.
18. Heymes C, Bendall JK, Ratajezak P, Cave AC, Samuel JL, Hasenfuss G, and Shah AM. Increased myocardial NADPH oxidase activity in human heart failure. J Am Coll Cardiol 41:2164-2171, 2003.
19. Hoffmann MS, Singh P, Wolk R, Romero-Corral A. Raghavakaimal S, and Somers VK. Microarray studies of genomic oxidative stress and cell cycle responses in obstructive sleep apnea. Antioxid Redox Signal 9: 661-669, 2007.
20. Hoshino Y, Shioji K, Nakamura H, Masutani H, and Yodoi J. From oxygen sensing to heart failure: role of thioredoxin. Antioxid Redox Signal 9: 689-699, 2007.
21. Humbert M, Sitbon O, and Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 351: 1425-1436, 2004.
22. Jain V. Clinical perspective of obstructive sleep apnea-induced cardiovascular complications. Antioxid Redox Signal 9: 701-710, 2007.
23. Jones RD, Hancock JT, and Morice AH. NADPH oxidase: a universal oxygen sensor? Free Radic Biol Med 29: 416-424, 2000.
24. Lavie P, Herer P, and Hoffstein V. Obstructive sleep apnoca syndrome as a risk factor for hypertension: population study. Br Med J 320: 479-482, 2000.
25. Lee SL, Wang WW, and Fanburg BL. Superoxide as an intermediate signal for serotonin-induced mitogenesis. Free Radic Biol Med 24: 855-858, 1998.
26. 2 signals 5-HT-induced ERK MAP kinase activation and mitogenesis of smooth muscle cells. Am J Physiol 281: L646-L652, 2001.
27. Li JM, Gall NP, Grieve DJ, Chen M, and Shah AM. Activation of NADPH oxidase during progression of cardiac hypertrophy to failure. Hypertension 40: 477-484, 2002.
28. + channels in pulmonary hypertension. Vascul Pharmacol 38: 25-33, 2002.
29. Michelotti GA, Bauman MJ, Smith MP, and Schwinn DA. Cloning and characterization of the rat alpha 1α-adrenergic receptor gene promoter. Demonstration of cell specificity and regulation by hypoxia. J Biol Chem 278: 8693-8705, 2003.
30. Nakagami H, Takemoto M, and Liao JK. NADPH oxidase-dcrived superoxide anion mediates angiotensin II-induced cardiac hypertrophy. J Mol Cell Cardiol 35: 851-859, 2003.
31. Nauser TD and Stites SW. Pulmonary hypertension: new perspectives. Congest Heart Fail 9: 155-162, 2003.
32. Nicolls MR and Voelkel NF. Hypoxia and the lung: beyond hypoxic vasoconstriction. Antioxid Redox Signal 9: 741-743, 2007.
33. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, D'Agostino RB, Newman AB, Lebowitz MD, and Pickering TG. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 283: 1829-1836, 2000.
34. Park A-M, Nagasc H, Kumar SV, and Suzuki YJ. Effects of intermittent hypoxia on the heart. Antioxid Redox Signal 9: 723-729, 2007.
35. Peker Y, Kraiczi H, Hedner J, Loth S, Johansson A, and Bende M. An independent association between obstructive sleep apnoea and coronary artery disease. Eur Respir J 14: 179-184, 1999.
36. Peppard PE, Young T, Palta M, and Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. New Engl J Med 342: 1378-1384, 2000.
37. Preston IR. Clinical perspective of hypoxia-mediated pulmonary hypertension. Antioxid Redox Signal 9: 711-721, 2007.
38. Privratsky JR, Wold LE, Sowers JR, Quinn MT, and Ren J. AT1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes: role of the AT1 receptor and NADPH oxidase. Hypertension 42: 206-212, 2003.
39. Qureshi A and Ballard RD. Obstructive sleep apnea. J Allergy Clin Immunol 112: 643-651, 2003.
40. Sajkov D, Cowie RJ, Thornton AT, Espinoza HA, and McEvoy RD. Pulmonary hypertension and hypoxemia in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 149: 416-422, 1994.
41. Schafer H, Koehler U, Ewig S, Hasper E, Tasci S, and Luderitz B. Obstructive sleep apnea as a risk marker in coronary artery disease. Cardiology 92: 79-84, 1999.
42. Schofield CJ and Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 5: 343-354, 2004.
43. 2, and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell 107: 1-3, 2001.
44. Shamsuzzaman AS, Gersh BJ, and Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 290: 1906-1914, 2003.
45. 2+ release from vascular smooth muscle sarcoplasmic reticulum. Am J Physiol 262: H114-H116, 1992.
46. Suzuki YJ and Ford GD. Redox regulation of signal transduction in cardiac and smooth muscle. J Mol Cell Cardiol 31: 345-353, 1999.
47. Suzuki YJ, Forman HJ, and Sevanian A. Oxidants as stimulators of signal transduction. Free Radic Biol Med 22: 269-285, 1997.
48. Suzuki YJ, Nagase H, Nic K, and Park AM. Redox control of growth factor signaling: recent advances in cardiovascular medicine. Antioxid Redox Signal 7: 829-834, 2005.
49. Suzuki YJ, Jain V, Park AM, and Day RM. Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases. Free Radic Biol Med 40: 1683-1692, 2006.
50. Sweeney M, and Yuan JX. Hypoxic pulmonary vasoconstriction: role of voltage-gated potassium channels. Respir Res 1: 40-48, 2000.
51. Taylor PB and McDonald GW. Hypoxia stimulates myocardial RNA synthesis and histone acetylation. Res Commun Chem Pathol Pharmacol 40: 349-352, 1983.
52. phox is a critical component of the superoxide-gencrating NADH/NADPH oxidase system and regulates angiotensin 11-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 271:23317-23321, 1996.
53. Ushio-Fukai M. VEGF signaling through NADPH oxidase-derived ROS. Antioxid Redox Signal 9: 731-739, 2007.
54. Vanden Hoek TL, Becker LB, Shao Z, Li C, and Schumacker PT. Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J Biol Chem 273: 18092-18098, 1998.
55. Voelkel NF, Quaife RA, Leinwand LA, Barst RJ, McGoon MD, Meldrum DR, Dupuis J, Long CS, Rubin LJ, Smark FW, Suzuki YJ, Gladwin M, Denholm EM, and Gail DB. Right ventricular function and failure: The need to know more. Report of a National Heart, Lung and Blood Institute Working Group on Cellular and Molecular Mechanisms of Right Heart Failure. Circulation 114: 1883-1891, 2006.
56. Wedgwood S, Dettman RW, and Black SM. ET-1 stimulates pulmonary arterial smooth muscle cell proliferation via induction of reactive oxygen species. Am J Physiol 281: L1058-L1067, 2001.
57. Wedgwood S and Black SM. Role of reactive oxygen species in vascular remodeling associated with pulmonary hypertension. Antioxid Redox Signal 5: 759-769, 2003.
58. Wilcox CS. Reactive oxygen species: roles in blood pressure and kidney function. Curr Hypertens Rep 4: 160-166, 2002.
59. Williams SE, Wootton P, Mason HS, Bould J, Iles DE, Riccardi D, Peers C, and Kemp PJ. Hemoxygenase-2 is an oxygen sensor for a calcium-sensitive potassium channel. Science 306: 2093-2097, 2004.
60. Wolin MS, Ahmad M, Gao Q, and Gupte SA. Cytosolic NAD(P)H regulation of redox signaling and vascular oxygen sensing. Antioxid Redox Signal 9: 671-678, 2007.
61. Wright G, Higgin JJ, Raines RT, Steenbergen C, and Murphy E. Activation of the prolyl hydroxylase oxygen-sensor results in induction of GLUT1, heme oxygenase-1, and nitric-oxide synthase proteins and confers protection from metabolic inhibition to cardiomyocytes. J Biol Chem 278: 20235-20239, 2003.
62. Xiao L, Pimentel DR, Wang J, Singh K, Colucci WS, and Sawyer DB. Role of reactive oxygen species and NAD(P)H oxidase in alpha(1)-adrenoceptor signaling in adult rat cardiac myocytes. Am J Physiol 282: C926-C934, 2002.
63. Young T, Palta M, Dempsey J, Skatrud, J, Weber S, and Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328: 1230-1235, 1993.
64. Zhang CL, McKinsey TA, Chang S, Antos CL, Hill JA, and Olson EN. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110: 479-488, 2002.